SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Calkins BM, Mendeloff AI. Epidemiology of inflammatory bowel disease. Epidemiol Rev. 1986; 8: 6091.
  • 2
    Bernstein CN. Extraintestinal manifestations of inflammatory bowel disease. Curr Gastroenterol Rep. 2001; 3: 477483.
  • 3
    Lakatos L, Pandur T, David G, et al. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study. World J Gastroenterol. 2003; 9: 23002307.
  • 4
    Mendoza JL, Lana R, Taxonera C, et al. [ Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn's disease and ulcerative colitis.] Med Clin (Barc). 2005; 125: 297300.
  • 5
    Repiso A, Alcantara M, Munoz-Rosas C, et al. Extraintestinal manifestations of Crohn's disease: prevalence and related factors. Rev Esp Enferm Dig. 2006; 98: 510517.
  • 6
    Grossman BJ, DeBenedetti CD. Extraintestinal manifestations of chronic inflammatory bowel disease in children. Proc Inst Med Chic. 1970; 28: 119.–
  • 7
    Stawarski A, Iwanczak B, Krzesiek E, et al. [ Intestinal complications and extraintestinal manifestations in children with inflammatory bowel disease.] Pol Merkur Lekarski. 2006; 20: 2225.
  • 8
    Heyman MB, Kirschner BS, Gold BD, et al. Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. J Pediatr. 2005; 146: 3540.
  • 9
    Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore). 1976; 55: 401412.
  • 10
    Rogler G, Scholmerich J. [ Extraintestinal manifestations of inflammatory bowel disease.] Med Klin (Munich). 2004; 99: 123130.
  • 11
    Bernstein CN, Blanchard JF, Rawsthorne P, et al. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2001; 96: 11161122.
    Direct Link:
  • 12
    Monsen U, Sorstad J, Hellers G, et al. Extracolonic diagnoses in ulcerative colitis: an epidemiological study. Am J Gastroenterol. 1990; 85: 711716.
  • 13
    Gupta N, Cohen SA, Bostrom AG, et al. Risk factors for initial surgery in pediatric patients with Crohn's disease. Gastroenterology. 2006; 130: 10691077.
  • 14
    Lakatos L, Pandur T, David G, et al. [ Extra-intestinal manifestation of IBD in Veszprem county (of Hungary): results of a 25-years follow-up study.] Orv Hetil. 2003; 144: 19651975.
  • 15
    Eidelwein AP, Thompson R, Fiorino K, et al. Disease presentation and clinical course in black and white children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2007; 44: 555560.
  • 16
    Orchard T. Extraintestinal complications of inflammatory bowel disease. Curr Gastroenterol Rep. 2003; 5: 512517.
  • 17
    Danzi JT. Extraintestinal manifestations of idiopathic inflammatory bowel disease. Arch Intern Med. 1988; 148: 297302.
  • 18
    Olsson R, Danielsson A, Jarnerot G, et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology. 1991; 100: 13191323.
  • 19
    Lee YM, Kaplan MM. Primary sclerosing cholangitis. N Engl J Med. 1995; 332: 924933.
  • 20
    Rasmussen HH, Fallingborg J, Mortensen PB, et al. Primary sclerosing cholangitis in patients with ulcerative colitis. Scand J Gastroenterol. 1992; 27: 732736.
  • 21
    Card TR, Solaymani-Dodaran M, West J. Incidence and mortality of primary sclerosing cholangitis in the UK: a population-based cohort study. J Hepatol. 2008; 48: 939944.
  • 22
    Lindor KD, Wiesner RH, MacCarty RL, Ludwig J, LaRusso NF. Advances in primary sclerosing cholangitis. Am J Med. 1990; 89: 7380.
  • 23
    Parlak E, Kosar Y, Ulker A, et al. Primary sclerosing cholangitis in patients with inflammatory bowel disease in Turkey. J Clin Gastroenterol. 2001; 33: 299301.
  • 24
    Schrumpf E, Elgjo K, Fausa O, et al. Sclerosing cholangitis in ulcerative colitis. Scand J Gastroenterol. 1980; 15: 689697.
  • 25
    Palm O, Moum B, Jahnsen J, et al. The prevalence and incidence of peripheral arthritis in patients with inflammatory bowel disease, a prospective population-based study (the IBSEN study). Rheumatology (Oxford). 2001; 40: 12561261.
  • 26
    Veloso FT, Carvalho J, Magro F. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol. 1996; 23: 2934.
  • 27
    Compston JE, Judd D, Crawley EO, et al. Osteoporosis in patients with inflammatory bowel disease. Gut. 1987; 28: 410415.
  • 28
    Vestergaard P. Prevalence and pathogenesis of osteoporosis in patients with inflammatory bowel disease. Minerva Med. 2004; 95: 469480.
  • 29
    Thearle M, Horlick M, Bilezikian JP, et al. Osteoporosis: an unusual presentation of childhood Crohn's disease. J Clin Endocrinol Metab. 2000; 85: 21222126.